In addition, analysis of 70 cervical cancer patients found that, The expression of Foxp3 and VISTA is associated with clinical staging, The group with double positive expression of Foxp3 and VISTA had the worst prognosis, The positive expression of Foxp3 and VISTA may serve as independent prognostic factors for cervical cancer, providing strong evidence for immunotherapy of cervical cancer (101). This evidence concerns the gene FOXP3 and cervical cancer.